The latest price target for CareDx (NASDAQ:CDNA) was reported by BTIG on November 5, 2024. The analyst firm set a price target for $35.00 expecting CDNA to rise to within 12 months (a possible 69.82% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for CareDx (NASDAQ:CDNA) was provided by BTIG, and CareDx maintained their buy rating.

The last upgrade for CareDx Inc happened on August 19, 2024 when BTIG raised their price target to $40. BTIG previously had a neutral for CareDx Inc.

The last downgrade for CareDx Inc happened on May 13, 2024 when Raymond James changed their price target from N/A to N/A for CareDx Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareDx was filed on November 5, 2024 so you should expect the next rating to be made available sometime around November 5, 2025.

While ratings are subjective and will change, the latest CareDx (CDNA) rating was a maintained with a price target of $40.00 to $35.00. The current price CareDx (CDNA) is trading at is $20.61, which is out of the analyst’s predicted range.